Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Rosenbaum, JF' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 185 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Brunswick, DJ; Amsterdam, JD; Fawcett, J; Quitkin, FM; Reimherr, FW; Rosenbaum, JF; Beasley, CM
      Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    2. Rosenbaum, JF
      Introduction - Early onset of antidepressant action

      JOURNAL OF CLINICAL PSYCHIATRY
    3. Leon, AC; Blier, P; Culpepper, L; Gorman, JM; Hirschfeld, RMA; Nierenberg, AA; Roose, SP; Rosenbaum, JF; Stahl, SM; Trivedi, MH
      An ideal trial to test differential onset of antidepressant effect

      JOURNAL OF CLINICAL PSYCHIATRY
    4. Hirschfeld, RMA; Nierenberg, AA; Gorman, JM; Roose, SP; Leon, AC; Blier, P; Culpepper, L; Rosenbaum, JF; Stahl, SM; Trivedi, MH
      Debate and discussion - Do some antidepressants have a faster onset of action than others?

      JOURNAL OF CLINICAL PSYCHIATRY
    5. Smoller, JW; Rosenbaum, JF; Biederman, J; Susswein, LS; Kennedy, J; Kagan, J; Snidman, N; Laird, N; Tsuang, MT; Faraone, SV; Schwarz, A; Slaugenhaupt, SA
      Genetic association analysis of behavioral inhibition using candidate locifrom mouse models

      AMERICAN JOURNAL OF MEDICAL GENETICS
    6. Smoller, JW; Acierno, JS; Rosenbaum, JF; Biederman, J; Pollack, MH; Meminger, S; Pava, JA; Chadwick, LH; White, C; Bulzacchelli, M; Slaugenhaupt, SA
      Targeted genome screen of panic disorder and anxiety disorder proneness using homology to murine QTL regions

      AMERICAN JOURNAL OF MEDICAL GENETICS
    7. Weinstock, L; Cohen, LS; Bailey, JW; Blatman, R; Rosenbaum, JF
      Obstetrical and neonatal outcome following clonazepam use during pregnancy: A case series

      PSYCHOTHERAPY AND PSYCHOSOMATICS
    8. Petersen, T; Gordon, JA; Kant, A; Fava, M; Rosenbaum, JF; Nierenberg, AA
      Treatment resistant depression and Axis I co-morbidity

      PSYCHOLOGICAL MEDICINE
    9. Biederman, J; Hirshfeld-Becker, DR; Rosenbaum, JF; Herot, C; Friedman, D; Snidman, N; Kagan, J; Faraone, SV
      Further evidence of association between behavioral inhibition and social anxiety in children

      AMERICAN JOURNAL OF PSYCHIATRY
    10. Biederman, J; Hirshfeld-Becker, DR; Rosenbaum, JF; Perenick, SG; Wood, J; Faraone, SV
      Lack of association between parental alcohol or drug addiction and behavioral inhibition in children

      AMERICAN JOURNAL OF PSYCHIATRY
    11. Biederman, J; Faraone, SV; Hirshfeld-Becker, DR; Friedman, D; Robin, JA; Rosenbaum, JF
      Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression

      AMERICAN JOURNAL OF PSYCHIATRY
    12. Spillmann, MK; Van der Does, AJW; Rankin, MA; Vuolo, RD; Alpert, JE; Nierenberg, AA; Rosenbaum, JF; Hayden, D; Schoenfeld, D; Fava, M
      Tryptophan depletion in SSRi-recovered depressed outpatients

      PSYCHOPHARMACOLOGY
    13. Kienke, AS; Rosenbaum, JF
      Efficacy of venlafaxine in the treatment of severe depression

      DEPRESSION AND ANXIETY
    14. Manfro, GG; Pollack, MH; Otto, MW; Worthington, JJ; Rosenbaum, JF; Scott, EL; Kradin, RL
      Cell-surface expression of L-selectin (CD62L) by blood lymphocytes: Correlates with affective parameters and severity of panic disorder

      DEPRESSION AND ANXIETY
    15. Mischoulon, D; Rosenbaum, JF; Messner, E
      Transfer to a new psychopharmacologist - Its effect on patients

      ACADEMIC PSYCHIATRY
    16. Otto, MW; Pollack, MH; Gould, RA; Worthington, JJ; McArdle, ET; Rosenbaum, JF
      A comparison of the efficacy of clonazepam and cognitive-behavioral group therapy for the treatment of social phobia

      JOURNAL OF ANXIETY DISORDERS
    17. Mischoulon, D; Nierenberg, AA; Kizilbash, L; Rosenbaum, JF; Fava, M
      Strategies for managing depression refractory to selective serotonin reuptake inhibitor treatment: A survey of clinicians

      CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE
    18. Fava, M; Vuolo, RD; Wright, EC; Nierenberg, AA; Alpert, JE; Rosenbaum, JF
      Fenfluramine challenge in unipolar depression with and without anger attacks

      PSYCHIATRY RESEARCH
    19. Fava, M; Rosenbaum, JF; Hoog, SL; Tepner, RG; Kopp, JB; Nilsson, ME
      Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression

      JOURNAL OF AFFECTIVE DISORDERS
    20. McGrath, PJ; Stewart, JW; Petkova, E; Quitkin, FM; Amsterdam, JD; Fawcett, J; Reimherr, FW; Rosenbaum, JF; Beasley, CM
      Predictors of relapse during fluoxetine continuation or maintenance treatment of major depression

      JOURNAL OF CLINICAL PSYCHIATRY
    21. Fredman, SJ; Fava, M; Kienke, AS; White, CN; Nierenberg, AA; Rosenbaum, JF
      Partial response, nonresponse, and relapse with selective serotonin reuptake inhibitors in major depression: A survey of current "next-step" practices

      JOURNAL OF CLINICAL PSYCHIATRY
    22. Rosenbaum, JF
      Expanding the use of anxiolytics in clinical practice - Introduction

      CLINICAL THERAPEUTICS
    23. Fava, M; Rankin, MA; Wright, EC; Alpert, JE; Nierenberg, AA; Pava, J; Rosenbaum, JF
      Anxiety disorders in major depression

      COMPREHENSIVE PSYCHIATRY
    24. Rosenbaum, JF; Heninger, G
      Vagus nerve stimulation for treatment-resistant depression

      BIOLOGICAL PSYCHIATRY
    25. Nierenberg, AA; Farabaugh, AH; Alpert, JE; Gordon, J; Worthington, JJ; Rosenbaum, JF; Fava, M
      Timing of onset of antidepressant response with fluoxetine treatment

      AMERICAN JOURNAL OF PSYCHIATRY
    26. Rosenbaum, JF; Biederman, J; Hirshfeld-Becker, DR; Kagan, J; Snidman, N; Friedman, D; Nineberg, A; Gallery, DJ; Faraone, SV
      A controlled study of behavioral inhibition in children of parents with panic disorder and depression

      AMERICAN JOURNAL OF PSYCHIATRY
    27. Mischoulon, D; Fava, M; Rosenbaum, JF
      Strategies for augmentation of SSRI treatment: A survey of an academic psychopharmacology practice

      HARVARD REVIEW OF PSYCHIATRY
    28. Mischoulon, D; Rosenbaum, JF
      The use of natural remedies in psychiatry: A commentary

      HARVARD REVIEW OF PSYCHIATRY
    29. Fava, M; Rosenbaum, JF; Kolsky, AR; Alpert, JE; Nierenberg, AA; Spillmann, M; Moore, C; Renshaw, P; Bottiglieri, T; Moroz, G; Magni, G
      Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    30. Amsterdam, JD; Garcia-Espana, F; Fawcett, J; Quitkin, FM; Reimherr, FW; Rosenbaum, JF; Beasley, C
      Blood pressure changes during short-term fluoxetine treatment

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    31. Cannon, B; Mulroy, R; Otto, MW; Rosenbaum, JF; Fava, M; Nierenberg, AA
      Dysfunctional attitudes and poor problem solving skills predict hopelessness in major depression

      JOURNAL OF AFFECTIVE DISORDERS
    32. Tedlow, J; Leslie, V; Keefe, BR; Alpert, J; Nierenberg, AA; Rosenbaum, JF; Fava, M
      Axis I and Axis II disorder comorbidity in unipolar depression with anger attacks

      JOURNAL OF AFFECTIVE DISORDERS
    33. Sonawalla, SB; Spillmann, MK; Kolsky, AR; Alpert, JE; Nierenberg, AA; Rosenbaum, JF; Fava, M
      Efficacy of fluvoxamine in the treatment of major depression with comorbidanxiety disorders

      JOURNAL OF CLINICAL PSYCHIATRY
    34. Moroz, G; Rosenbaum, JF
      Efficacy, safety, and gradual discontinuation of clonazepam in panic disorder: A placebo-controlled, multicenter study using optimized dosages

      JOURNAL OF CLINICAL PSYCHIATRY
    35. Zajecka, J; Amsterdam, JD; Quitkin, FM; Reimherr, FW; Rosenbaum, JF; Tamura, RN; Sundell, KL; Michelson, D; Beasley, CM
      Changes in adverse events reported by patients during 6 months of fluoxetine therapy

      JOURNAL OF CLINICAL PSYCHIATRY
    36. Nierenberg, AA; Keefe, BR; Leslie, VC; Alpert, JE; Pava, JA; Worthington, JJ; Rosenbaum, JF; Fava, M
      Residual symptoms in depressed patients who respond acutely to fluoxetine

      JOURNAL OF CLINICAL PSYCHIATRY
    37. Fava, M; Rosenbaum, JF
      Anger attacks in patients with depression

      JOURNAL OF CLINICAL PSYCHIATRY
    38. Alpert, JE; Fava, M; Uebelacker, LA; Nierenberg, AA; Pava, JA; Worthington, JJ; Rosenbaum, JF
      Patterns of axis I comorbidity in early-onset versus late-onset major depressive disorder

      BIOLOGICAL PSYCHIATRY
    39. Michelson, D; Amsterdam, JD; Quitkin, FM; Reimherr, FW; Rosenbaum, JF; Zajecka, J; Sundell, KL; Kim, Y; Beasley, CM
      Changes in weight during a 1-year trial of fluoxetine

      AMERICAN JOURNAL OF PSYCHIATRY
    40. Rosenbaum, JF; Fredman, SJ
      Pramipexole treatment for cocaine cravings

      AMERICAN JOURNAL OF PSYCHIATRY
    41. Sonawalla, SB; Renshaw, PF; Moore, CM; Alpert, JE; Nierenberg, AA; Rosenbaum, JF; Fava, M
      Compounds containing cytosolic choline in the basal ganglia: A potential biological marker of true drug response to fluoxetine

      AMERICAN JOURNAL OF PSYCHIATRY
    42. Rosenbaum, JF; Hylan, TR
      Costs of depressive disorders: A review

      DEPRESSIVE DISORDERS, VOL 1
    43. FREDMAN SJ; ROSENBAUM JF
      RECURRENT DEPRESSION, RESISTANT CLINICIAN

      Harvard review of psychiatry
    44. Amsterdam, JD; Garcia-Espana, F; Fawcett, J; Quitkin, FM; Reimherr, FW; Rosenbaum, JF; Schweizer, E; Beasley, C
      Efficacy and safety of fluoxetine in treating bipolar II major depressive episode

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    45. NIERENBERG AA; DOUGHERTY D; ROSENBAUM JF
      DOPAMINERGIC AGENTS AND STIMULANTS AS ANTIDEPRESSANT AUGMENTATION STRATEGIES

      The Journal of clinical psychiatry
    46. COHEN LS; ROSENBAUM JF
      PSYCHOTROPIC-DRUG USE DURING PREGNANCY - WEIGHING THE RISKS

      The Journal of clinical psychiatry
    47. GLAZER WM; ROSENBAUM JF
      MANAGED CARE VERSUS MANAGED MONEY

      The Journal of clinical psychiatry
    48. GLAZER WM; ROSENBAUM JF
      MANAGED CARE VERSUS MANAGED MONEY - INTRODUCTION

      The Journal of clinical psychiatry
    49. GLAZER WM; ROSENBAUM JF
      ROLE OF MEDICATION IN MANAGED CARE FOR DEPRESSION

      The Journal of clinical psychiatry
    50. GLAZER WM; ROSENBAUM JF
      ROLE OF PSYCHIATRISTS IN MANAGED CARE SYSTEMS

      The Journal of clinical psychiatry
    51. NIERENBERG AA; ALPERT JE; PAVA J; ROSENBAUM JF; FAVA M
      COURSE AND TREATMENT OF ATYPICAL DEPRESSION

      The Journal of clinical psychiatry
    52. ROSENBAUM JF
      DEPRESSION AND ITS SUBTYPES - A TREATMENT UPDATE

      The Journal of clinical psychiatry
    53. SMOLLER JW; ROSENBAUM JF; BIEDERMAN JB; KAGAN J; SUSSWEIN L; HELBLING L; SLAUGENHAUPT S
      A NEW STRATEGY FOR THE GENETIC-ANALYSIS OF ANXIOUS TEMPERAMENT

      American journal of medical genetics
    54. Worthington, JJ; Pollack, MH; Otto, MW; McLean, RYS; Moroz, G; Rosenbaum, JF
      Long-term experience with clonazepam in patients with a primary diagnosis of panic disorder

      PSYCHOPHARMACOLOGY BULLETIN
    55. ROSENBAUM JF; FAVA M; HOOG SL; ASCROFT RC; KREBS WB
      SELECTIVE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A RANDOMIZED CLINICAL-TRIAL

      Biological psychiatry
    56. FAVA M; ROSENBAUM JF; HOOG S; TEPNER R; KOPP J; SAYLER M
      FLUOXETINE VERSUS SERTRALINE AND PAROXETINE IN MAJOR DEPRESSION - SAFETY AND EFFICACY IN PATIENTS WITH LOW AND HIGH BASE-LINE INSOMNIA

      Biological psychiatry
    57. FAVA M; ROSENBAUM JF; HOOG S; TEPNER R; KOPP J; SAYLER M
      FLUOXETINE VERSUS SERTRALINE AND PAROXETINE IN MAJOR DEPRESSION - SAFETY AND EFFICACY IN ANXIOUS AND NONANXIOUS SUBGROUPS

      Biological psychiatry
    58. REIMHERR FW; AMSTERDAM JD; QUITKIN FM; ROSENBAUM JF; FAVA M; ZAJECKA J; BEASLEY CM; MICHELSON D; ROBACK P; SUNDELL K
      OPTIMAL LENGTH OF CONTINUATION THERAPY IN DEPRESSION - A PROSPECTIVE ASSESSMENT DURING LONG-TERM FLUOXETINE TREATMENT

      The American journal of psychiatry
    59. AMSTERDAM JD; FAWCETT J; QUITKIN FM; REIMHERR FW; ROSENBAUM JF; MICHELSON D; BEASLEY CM
      FLUOXETINE AND NORFLUOXETINE - DR. AMSTERDAM AND COLLEAGUES REPLY

      The American journal of psychiatry
    60. Rosenbaum, JF; Fava, M
      Approach to the patient with depression

      MGH GUIDE TO PSYCHIATRY IN PRIMARY CARE
    61. HIRSHFELD DR; BIEDERMAN J; BRODY L; FARAONE SV; ROSENBAUM JF
      EXPRESSED EMOTION TOWARD CHILDREN WITH BEHAVIORAL-INHIBITION - ASSOCIATIONS WITH MATERNAL ANXIETY DISORDER

      Journal of the American Academy of Child and Adolescent Psychiatry
    62. HIRSHFELD DR; BIEDERMAN J; BRODY L; FARAONE SV; ROSENBAUM JF
      ASSOCIATIONS BETWEEN EXPRESSED EMOTION AND CHILD BEHAVIORAL-INHIBITION AND PSYCHOPATHOLOGY - A PILOT-STUDY

      Journal of the American Academy of Child and Adolescent Psychiatry
    63. ZARETSKY AE; FAVA M; DAVIDSON KG; PAVA JA; MATTHEWS J; ROSENBAUM JF
      ARE DEPENDENCY AND SELF-CRITICISM RISK-FACTORS FOR MAJOR DEPRESSIVE DISORDER

      Canadian journal of psychiatry
    64. ROSENBAUM JF; MOROZ G; BOWDEN CL
      CLONAZEPAM IN THE TREATMENT OF PANIC-DISORDER WITH OR WITHOUT AGORAPHOBIA - A DOSE-RESPONSE STUDY OF EFFICACY, SAFETY, AND DISCONTINUANCE

      Journal of clinical psychopharmacology
    65. SCHATZBERG AF; HADDAD P; KAPLAN EM; LEJOYEUX M; ROSENBAUM JF; YOUNG AH; ZAJECKA J
      SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME - A HYPOTHETICAL DEFINITION

      The Journal of clinical psychiatry
    66. SCHATZBERG AF; HADDAD P; KAPLAN EM; LEJOYEUX M; ROSENBAUM JF; YOUNG AH; ZAJECKA J
      POSSIBLE BIOLOGICAL MECHANISMS OF THE SEROTONIN REUPTAKE INHIBITOR DISCONTINUATION SYNDROME

      The Journal of clinical psychiatry
    67. ROSENBAUM JF; ZAJECKA J
      CLINICAL MANAGEMENT OF ANTIDEPRESSANT DISCONTINUATION

      The Journal of clinical psychiatry
    68. ROSENBAUM JF
      TREATMENT OF PANIC DISORDER - THE STATE-OF-THE-ART - INTRODUCTION

      The Journal of clinical psychiatry
    69. ROSENBAUM JF
      TREATMENT-RESISTANT PANIC DISORDER

      The Journal of clinical psychiatry
    70. ROSENBAUM JF
      TREATMENT OF PANIC DISORDER - THE STATE-OF-THE-ART - CONCLUSION

      The Journal of clinical psychiatry
    71. FAVA M; BURGER J; MCCOLL R; ALPERT J; NIERENBERG A; PAVA J; ROSENBAUM JF
      COGNITIVE CHANGES IN RELATIONSHIP TO PATTERNS OF RESPONSE TO ANTIDEPRESSANT DRUG-TREATMENT

      Psychopharmacology bulletin
    72. FAVA M; MULROY R; KOLSKY AR; ALPERT JE; NIERENBERG AA; ROSENBAUM JF
      THE EMERGENCE OF ADVERSE EVENTS FOLLOWING VENLAFAXINE-ER DISCONTINUATION

      Psychopharmacology bulletin
    73. WORTHINGTON JJ; POLLACK MH; MOROZ G; OTTO MW; MCLEAN RYS; ROSENBAUM JF
      NATURALISTIC STUDY OF CLONAZEPAM IN PANIC DISORDER

      Psychopharmacology bulletin
    74. FAVA M; NIERENBERG AA; QUITKIN FM; ZISOOK S; PEARLSTEIN T; STONE A; ROSENBAUM JF
      A PRELIMINARY-STUDY ON THE EFFICACY OF SERTRALINE AND IMIPRAMINE ON ANGER ATTACKS IN ATYPICAL DEPRESSION AND DYSTHYMIA

      Psychopharmacology bulletin
    75. ALPERT JE; UEBELACKER LA; MCLEAN NE; NIERENBERG AA; PAVA JA; WORTHINGTON JJ; TEDLOW JR; ROSENBAUM JF; FAVA M
      SOCIAL PHOBIA, AVOIDANT PERSONALITY-DISORDER AND ATYPICAL DEPRESSION - COOCCURRENCE AND CLINICAL IMPLICATIONS

      Psychological medicine
    76. COHEN LS; ROSENBAUM JF
      BIRTH OUTCOMES IN PREGNANT-WOMEN TAKING FLUOXETINE

      The New England journal of medicine
    77. WORTHINGTON JJ; POLLACK MH; OTTO MW; GOULD RA; SABATINO SA; GOLDMAN L; ROSENBAUM JF; LEE TH
      PANIC DISORDER IN EMERGENCY WARD PATIENTS WITH CHEST PAIN

      The Journal of nervous and mental disease
    78. FAVA M; ABRAHAM M; CLANCYCOLECCHI K; PAVA JA; MATTHEWS J; ROSENBAUM JF
      EATING DISORDER SYMPTOMATOLOGY IN MAJOR DEPRESSION

      The Journal of nervous and mental disease
    79. FAVA M; UEBELACKER LA; ALPERT JE; NIERENBERG AA; PAVA JA; ROSENBAUM JF
      MAJOR DEPRESSIVE SUBTYPES AND TREATMENT RESPONSE

      Biological psychiatry
    80. RENSHAW PF; LAFER B; BABB SM; FAVA M; STOLL AL; CHRISTENSEN JD; MOORE CM; YURGELUNTODD DA; BONELLO CM; PILLAY SS; ROTHSCHILD AJ; NIERENBERG AA; ROSENBAUM JF; BRUCE BM
      BASAL GANGLIA CHOLINE LEVELS IN DEPRESSION AND RESPONSE TO FLUOXETINETREATMENT - AN IN-VIVO PROTON MAGNETIC-RESONANCE SPECTROSCOPY STUDY

      Biological psychiatry
    81. AMSTERDAM JD; FAWCETT J; QUITKIN FM; REIMHERR FW; ROSENBAUM JF; MICHELSON D; HORNIGROHAN M; BEASLEY CM
      FLUOXETINE AND NORFLUOXETINE PLASMA-CONCENTRATIONS IN MAJOR DEPRESSION - A MULTICENTER STUDY

      The American journal of psychiatry
    82. FAVA M; BORUS JS; ALPERT JE; NIERENBERG AA; ROSENBAUM JF; BOTTIGLIERI T
      FOLATE, VITAMIN-B-12, AND HOMOCYSTEINE IN MAJOR DEPRESSIVE DISORDER

      The American journal of psychiatry
    83. FAVA M; MULROY R; ALPERT J; NIERENBERG AA; ROSENBAUM JF
      EMERGENCE OF ADVERSE EVENTS FOLLOWING DISCONTINUATION OF TREATMENT WITH EXTENDED-RELEASE VENLAFAXINE

      The American journal of psychiatry
    84. ROSENBAUM JF
      MIRTAZAPINE REVISITED

      American family physician
    85. OSULLIVAN RL; FAVA M; AGUSTIN C; BAER L; ROSENBAUM JF
      SENSITIVITY OF THE 6-ITEM HAMILTON DEPRESSION RATING-SCALE

      Acta psychiatrica Scandinavica
    86. SMOLLER JW; POLLACK MH; OTTO MW; ROSENBAUM JF; KRADIN RL
      PANIC ANXIETY, DYSPNEA, AND RESPIRATORY-DISEASE - THEORETICAL AND CLINICAL CONSIDERATIONS

      American journal of respiratory and critical care medicine
    87. ROSENBAUM JF; POLLOCK RA
      DEPRESSIONS OF MILDER SEVERITY - LISTENING TO DATA

      Harvard review of psychiatry
    88. BRUDER GE; OTTO MW; MCGRATH PJ; STEWART JW; FAVA M; ROSENBAUM JF; QUITKIN FM
      DICHOTIC-LISTENING BEFORE AND AFTER FLUOXETINE TREATMENT FOR MAJOR DEPRESSION - RELATIONS OF LATERALITY TO THERAPEUTIC RESPONSE

      Neuropsychopharmacology
    89. ALPERT JE; MADDOCKS A; NIERENBERG AA; OSULLIVAN R; PAVA JA; WORTHINGTON JJ; BIEDERMAN J; ROSENBAUM JF; FAVA M
      ATTENTION-DEFICIT HYPERACTIVITY DISORDER IN CHILDHOOD AMONG ADULTS WITH MAJOR DEPRESSION

      Psychiatry research
    90. MANFRO GG; OTTO MW; MCARDLE ET; WORTHINGTON JJ; ROSENBAUM JF; POLLACK MH
      RELATIONSHIP OF ANTECEDENT STRESSFUL LIFE EVENTS TO CHILDHOOD AND FAMILY HISTORY OF ANXIETY AND THE COURSE OF PANIC DISORDER

      Journal of affective disorders
    91. FAVA M; ABRAHAM M; ALPERT J; NIERENBERG AA; PAVA JA; ROSENBAUM JF
      GENDER DIFFERENCES IN AXIS-I COMORBIDITY AMONG DEPRESSED OUTPATIENTS

      Journal of affective disorders
    92. ROSENBAUM JF; POLLACK MH; POLLOCK RA
      CLINICAL ISSUES IN THE LONG-TERM TREATMENT OF PANIC DISORDER

      The Journal of clinical psychiatry
    93. POLLACK MH; WORTHINGTON JJ; OTTO MW; MAKI KM; SMOLLER JW; MANFRO GG; RUDOLPH R; ROSENBAUM JF
      VENLAFAXINE FOR PANIC DISORDER - RESULTS FROM A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

      Psychopharmacology bulletin
    94. NIERENBERG AA; MCLEAN NE; ALPERT JE; WORTHINGTON JJ; ROSENBAUM JF; FAVA M
      DOES EARLY NONRESPONSE TO FLUOXETINE PREDICT POOR 8-WEEK OUTCOME - A REPLICATION STUDY

      Psychopharmacology bulletin
    95. POLLACK MH; WORTHINGTON JJ; OTTO MW; SMOLLER JW; MAKI KM; RUDOLPH R; ROSENBAUM JF
      DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF VENLAFAXINE FOR PANIC DISORDER

      Psychopharmacology bulletin
    96. SMOLLER JW; POLLACK MH; ROSENBAUM JF; KRADIN R
      SERTRALINE TREATMENT OF DYSPNEA IN PATIENTS WITH RESPIRATORY-DISEASE

      Psychopharmacology bulletin
    97. WEINSTOCK L; COHEN LS; ROBERTSON L; BLATMAN R; SICHEL D; GRUSH L; BIRNBAUM CS; BAILEY J; SHUMAKER DM; ROSENBAUM JF
      CLONAZEPAM USE DURING PREGNANCY IN WOMEN WITH PANIC DISORDER

      Psychopharmacology bulletin
    98. WORTHINGTON J; POLLACK MH; OTTO MW; GOULD RA; MCARDLE ET; ROSENBAUM JF
      EFFECT OF LIFETIME HISTORY OF ALCOHOL OR SUBSTANCE DEPENDENCE ON SEVERITY AND TREATMENT OF PANIC DISORDER

      Psychopharmacology bulletin
    99. WORTHINGTON J; FAVA M; AGUSTIN C; ALPERT J; NIERENBERG AA; PAVA JA; ROSENBAUM JF
      CONSUMPTION OF ALCOHOL, NICOTINE, AND CAFFEINE AMONG DEPRESSED OUTPATIENTS - RELATIONSHIP WITH RESPONSE TO TREATMENT

      Psychosomatics
    100. DEMOPULOS C; FAVA M; MCLEAN NE; ALPERT JE; NIERENBERG AA; ROSENBAUM JF
      HYPOCHONDRIACAL CONCERNS IN DEPRESSED OUTPATIENTS

      Psychosomatic medicine


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 10/08/20 alle ore 07:38:59